CURE Pharmaceutical  logo — We improve lives by redefining how medicines are delivered a...

CURE Pharmaceutical

We improve lives by redefining how medicines are delivered and experienced. Partner with us to get #PoweredByCUREfilm

Founded 2011 United States United States 47 employees Debt Financing Total: $29.66M Biotechnology, Manufacturing +1

General Information

Company Name CURE Pharmaceutical
Founded Year 2011
Location United States United States
Founders / Decision Makers
Team member
Employees 47
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with CURE Pharmaceutical . To contact CURE Pharmaceutical , visit curepharmaceutical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CURE Pharmaceutical compare?

A PDF of CURE Pharmaceutical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CURE Pharmaceutical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CURE Pharmaceutical

Cure Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. With its industry-leading full-service cGMP manufacturing facility, the company is a preeminent developer and manufacturer of a patented and proprietary delivery system, CureFilm™, which is considered the most advanced oral thin film on the market today. Cure Pharmaceutical has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. It has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. Founded in 2011 and headquartered in the United States, Cure Pharmaceutical received a $625.00K debt financing investment on 14 September 2022. The company's slogan, "We improve lives by redefining how medicines are delivered and experienced. Partner with us to get #PoweredByCUREfilm," reflects its mission to improve people's lives by redefining medicine delivery and experience.

Business keywords: Drug delivery, Pharmaceuticals, Medicine, Cannabis sector, Oral thin films, Biotech, Patented delivery systems, Therapeutic categories, Patient experience, Transdermal formulations, Endocannabinoids, Healthcare innovation, Advanced dosage forms, Vertical integration

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $625.00K -
14 Sep 2022
Post IPO Debt $10.00M -
02 Nov 2020
Post IPO Equity $19.04M -
29 May 2019

CURE Pharmaceutical Alternatives & Competitors

View All Alternatives
CURE Pharmaceutical vs

We CARE. We CREATE. We DELIVER.

Grant
326 employees
Biotechnology, Health Care
CURE Pharmaceutical vs

R&D of therapeutic consumer and medical products. 🌱 Helping new and existing brands from concept to...

Corporate Round
6 employees
Biopharma, Biotechnology
CURE Pharmaceutical vs

Neutro Pharma's mission is to develop, produce and market safe, effective medicines and healthcare p...

345 employees
Biotechnology, Manufacturing

FAQ About CURE Pharmaceutical

We improve lives by redefining how medicines are delivered and experienced. Partner with us to get #PoweredByCUREfilm
CURE Pharmaceutical was founded in 2011.
CURE Pharmaceutical is headquartered in United States.
CURE Pharmaceutical operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on Drug delivery, Pharmaceuticals, Medicine and Cannabis sector.
CURE Pharmaceutical has approximately 47 employees.
CURE Pharmaceutical has completed 3 funding rounds, raising a total of $29.66M. The latest funding stage is Debt Financing.
Top alternatives and competitors to CURE Pharmaceutical include LTS Lohmann Therapie-Systeme AG, Concept Matrix Solutions, Inc., Neutro Pharma (Pvt.) Ltd, Psycheceutical, SOMAÍ. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CURE Pharmaceutical and LTS Lohmann Therapie-Systeme AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CURE Pharmaceutical , https://bouncewatch.com/company/cure-pharmaceutical, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes